title: Pharmacotherapy of unstable angina.
abstract: All patients with unstable angina should be admitted to a coronary or an intensive care unit. There should be an attempt to classify the patient according to the proposed Braunwald nomenclature. If the patient has a secondary cause for unstable angina (e.g., tachyarrhythmia, heart failure, fever, thyrotoxicosis, severe hypertension, hypoxia, unusual emotional stress, or anemia), this condition should be treated initially with therapy specific for that etiology. If the patient does not have a secondary etiology, therapy should be initiated with nitrates, preferably intravenous nitroglycerin. Heparin should be concomitantly administered. If the patient cannot receive heparin, aspirin should be initiated. All patients should receive beta-blockers. If the patient cannot take a beta-blocker, a calcium antagonist (probably diltiazem) should be initiated. However, if the patient is refractory to beta-blockers, the dihydropyridine nifedipine should be added. Failure to all pharmacologic interventions necessitates a progressive invasive approach dictated by the potential surgical risk of the patient. Long-term aspirin and beta-blockers should be strongly considered.
authors.affiliation: Department of Medicine, Medical College of Georgia, Augusta 30912-3150.
authors.forename: L M
authors.initials: LM
authors.lastname: Prisant
authors.forename: T
authors.initials: T
authors.lastname: von Dohlen
authors.forename: W
authors.initials: W
authors.lastname: Rogers
authors.forename: J L
authors.initials: JL
authors.lastname: Houghton
authors.forename: A A
authors.initials: AA
authors.lastname: Carr
authors.forename: M J
authors.initials: MJ
authors.lastname: Frank
mesh_terms: D000789:Angina, Unstable / Q000188:drug therapy*; D006801:Humans